Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
69.14
-1.09 (-1.55%)
May 13, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 28, 2024 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | NaN - NaN |
| Plasma Products and Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Plasma Products and Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Products and Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Products and Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Products and Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Products and Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Plasma | 547.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Plasma Growth | -2.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center | 276.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Growth | -1.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hospital | 545.71M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Growth | 27.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Effect of Exchange Rates on | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Effect of Exchange Rates on Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 28, 2024 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | NaN - NaN |
| Plasma Segment Operating Income | 281.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Plasma Segment Operating Income Growth | -9.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Segment Operating Income | 105.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Segment Operating Income Growth | -5.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Segment Operating Income | 227.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Segment Operating Income Growth | 29.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 28, 2024 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | NaN - NaN |
| United States | 1.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 6.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 62.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 7.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 178.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 18.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 97.97M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | -8.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic | 25.91M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Growth | 410.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|